Matthew Baker
Directeur/Membre du Conseil chez FUSION ANTIBODIES PLC
Fortune : 6 309 $ au 30/04/2024
Provenance du réseau au premier degré de Matthew Baker
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Medical/Nursing Services | 11 | |
Holding Company | Biotechnology | 7 | |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matthew Baker via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
Warwick Business School | College/University | Masters Business Admin Masters Business Admin | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Chief Investment Officer Director/Board Member | |
OXFORD BIOMEDICA PLC | Biotechnology | Director of Finance/CFO | |
University of Oxford | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
H.J. Heinz Co. Ltd.
H.J. Heinz Co. Ltd. Food DistributorsDistribution Services H.J. Heinz Co. Ltd. produces, processes, and distributes food products. It also offers beans, sandwich spreads, fruit spreads, jams and jellies, cookies and cereal bars, spaghetti sauces, canned and microwave soups, ready entree meals, ready breakfasts, and canned & dry pasta products. The company was founded by Henry J. Heinz in 1917 and is headquartered in Hayes, the united Kingdom. | Food Distributors | Corporate Officer/Principal | |
The University of Southampton | College/University | Doctorate Degree Doctorate Degree | |
Queen's University of Belfast | College/University | Undergraduate Degree Doctorate Degree | |
East Carolina University | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Corporate Officer/Principal | |
BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member | |
Sheffield Hallam University | College/University | Undergraduate Degree | |
University of Aarhus | College/University | Doctorate Degree Doctorate Degree | |
Oxford Immunotec Ltd.
Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
West Midlands Enterprise Ltd.
West Midlands Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services West Midlands Enterprise Ltd. operates as an alternative investment manager. It provides IT and business consultancy services. The company was founded in 1982 and is headquartered in Solihull, the United Kingdom. | Miscellaneous Commercial Services | Private Equity Investor | |
IP2IPO Innovations Ltd.
IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
Archimedes Pharma Ltd.
Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
Molten Ventures (Private Equity)
Molten Ventures (Private Equity) Investment ManagersFinance Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Coopers & Lybrand (London)
Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Founder | |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | Miscellaneous Commercial Services | Director/Board Member | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Chief Investment Officer Director of Finance/CFO | |
Mercia Fund Management Ltd.
Mercia Fund Management Ltd. Investment ManagersFinance Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain. | Investment Managers | Chief Executive Officer | |
nanoTherics Ltd.
nanoTherics Ltd. Medical SpecialtiesHealth Technology nanoTherics Ltd. develops and manufactures magnetic nanoparticle-based products. Its product range includes devices and reagents for magnet assisted transfection and delivery of biomaterials into cells for the life science research and development market as well as products for nanoparticle heating applications. The company was founded by Jon Dobson and Neil Farrow in 2007 and is headquartered in Newcastle-under-Lyme, the United Kingdom. | Medical Specialties | Chairman | |
PolyTherics Ltd.
PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Abzena (Cambridge) Ltd.
Abzena (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Abzena (Cambridge) Ltd. provides antibody engineering and immunogenicity screening services. The company was founded in 2004 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
The Native Antigen Co. Ltd.
The Native Antigen Co. Ltd. Miscellaneous Commercial ServicesCommercial Services The Native Antigen Co. Ltd. develops viral vectors technologies. Its products include bacterial antigens, protozoal, and viral antigens. The company was founded by Nick Roesen and Andrew Maxwell in 2010 and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
HORIZON DISCOVERY GROUP PLC | Medical Specialties | Founder | |
MERCIA ASSET MANAGEMENT PLC | Financial Conglomerates | Chief Executive Officer | |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Exonate Ltd.
Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Queen's University Belfast A.F.C. | College/University | Doctorate Degree Undergraduate Degree | |
4basebio Slu | Director/Board Member | ||
Enhanc3D Genomics Ltd.
Enhanc3D Genomics Ltd. BiotechnologyHealth Technology Enhanc3D Genomics is a private functional genomics company based in Cambridge, UK. Enhanc3D Genomics is developing a technology to unlock the full potential of the three-dimensional organization of the human genome. The British company's focus is on the non-coding regions of the genome, aiming to identify disease-associated genetic interactions and revolutionize target and biomarker discovery. The company's unique approach has the potential to make precision medicine an everyday reality for patients. Enhanc3D Genomics Ltd. was founded by Mikhail Spivakov, Peter Fraser, and Stefan Schönfelder. The CEO is Hazel Jones. | Biotechnology | Chairman | |
BIOFRONTERA INC. | Pharmaceuticals: Major | Director/Board Member | |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
4basebio Discovery Ltd. | Director/Board Member | ||
I2i Capital Ltd. | Director/Board Member | ||
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Founder |
Statistiques
Internationale
Royaume-Uni | 38 |
Etats-Unis | 8 |
Allemagne | 3 |
Danemark | 3 |
Suède | 2 |
Sectorielle
Health Technology | 20 |
Commercial Services | 11 |
Consumer Services | 10 |
Finance | 7 |
Distribution Services | 3 |
Opérationnelle
Director/Board Member | 151 |
Corporate Officer/Principal | 49 |
Chief Executive Officer | 31 |
Founder | 17 |
Doctorate Degree | 17 |
Relations les plus connectées
Insiders | |
---|---|
Nigel Pitchford | 29 |
Anker Gunvald Lundemose | 25 |
Colin Walsh | 23 |
Mark Payton | 20 |
Alan Mawson | 19 |
Tim Watts | 17 |
John Sørensen Haurum | 17 |
Heikki Lanckriet | 17 |
Hiromichi Kimura | 16 |
Christopher Torrance | 13 |
Simon Douglas | 13 |
Julian Matthew Smith | 13 |
Richard Jones | 10 |
Pietro Puglisi | 9 |
Robert James | 8 |
- Bourse
- Insiders
- Matthew Baker
- Connexions Sociétés